IP Library Assignment 057089/0263
Patent Assignment
Reel/Frame 057089/0263

Nunc Pro Tunc Assignment

Recorded: 2021-08-05 Pages: 6
Assignor
MERCK SHARP & DOHME LIMITED
Executed: 2020-11-01
Assignee
MERCK SHARP & DOHME (UK) LIMITED
HERTFORD ROAD, HODDESDON, HERTFORDSHIRE EN11 9BU, UNITED KINGDOM
Covered Properties (20)
Imidazo-Pyrimidine Derivatives as Ligands for Gaba Receptors
Patent: 6,900,215 →
Application: 10/100,797 →
Publication: US 2002/0193385
Novel Cyclohexyl Sulphones
Patent: 6,984,663 →
Application: 10/223,993 →
Publication: US 2003/0114496
Sulfamides as Gamma-Secretase Inhibitors
Patent: 7,138,400 →
Application: 10/415,751 →
Publication: US 2004/0049038
Heteroaryl Substituted Spriocyclic Sulfamides for Inhibition of Gamma Secretase
Patent: 7,041,689 →
Application: 10/512,810 →
Publication: US 2005/0182109
Cyclohexyl Sulphones as Gamma-Secretase Inhibitors
Patent: 7,410,964 →
Application: 10/555,034 →
Publication: US 2006/0281737
Cyclohexyl Sulphones as Gamma-Secretase Inhibitors
Patent: 6,890,956 →
Application: 10/679,902 →
Publication: US 2004/0121995
Cyclic Sulfonamides for Inhibition of Gamma-Secretase
Patent: 7,342,009 →
Application: 10/845,833 →
Publication: US 2004/0230054
Diarylsulfones as 5-HT2A Antagonists
Patent: 7,217,740 →
Application: 11/212,789 →
Publication: US 2006/0052445
Novel Cyclohexyl Sulphones
Patent: 7,304,094 →
Application: 11/261,365 →
Publication: US 2006/0041020
Heteroaryl Substituted Spirocyclic Sulfamides for Inhibition of Gamma Secretase
Patent: 7,282,513 →
Application: 11/366,866 →
Publication: US 2006/0173054
Cyclohexanesulfonyl Derivatives as GLYT1 Inhibitors to Treat Schizophrenia
Patent: 7,626,056 →
Application: 11/446,735 →
Publication: US 2006/0276655
Piperidines and Related Compounds for Treatment of Alzheimer's Disease
Patent: 7,638,629 →
Application: 11/664,678 →
Publication: US 2008/0021043
Sulphones Which Modulate the Action of Gammasecretase
Patent: 7,598,386 →
Application: 11/788,888 →
Publication: US 2007/0213329
Piperidine and Azetidine Derivatives as GLYT1 Inhibitors
Patent: 7,655,644 →
Application: 11/792,111 →
Publication: US 2008/0090796
Diarylsulfones as 5-HT2A Antagonists
Patent: 7,468,393 →
Application: 11/796,389 →
Publication: US 2007/0203205
Sulphamides for Treatment of Cancer
Patent: 8,242,103 →
Application: 11/920,450 →
Publication: US 2009/0197904
Inhibitors of GLYT1 Transporters
Patent: 8,163,956 →
Application: 11/922,074 →
Publication: US 2009/0286765
Sulphones Which Modulate the Action of Gamma Secretase
Patent: 7,595,344 →
Application: 12/151,296 →
Publication: US 2009/0131419
Cyclohexanesulfonyl Derivatives as GLYT1 Inhibitors to Treat Schizophrenia
Patent: 7,851,638 →
Application: 12/571,904 →
Publication: US 2010/0029726
Formulations for C-Met Kinase Inhibitors
Patent: 9,238,571 →
Application: 13/498,600 →
Publication: US 2012/0241402
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Address May 10, 2022
From: MERCK SHARP & DOHME (UK) LIMITED
To: MERCK SHARP & DOHME (UK) LIMITED
Reel/Frame 060110/0121 →